Ticker

Mitesco (OTCMKTS:MITI - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Profitability This table compares Mitesco and 10x Genomics' net

VERO BEACH, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Mitesco, Inc. (OTCQB: MITI) (“Mitesco” or the “Company”) today announced the continued expansion of its small-format data center strategy through the development of a new edge computing services platform.

New capital commitment from a longtime investor fuels pipeline of acquisitions and drives expansion across core and emerging business lines VERO BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- Mitesco, Inc. (OTCQB: MITI) ("Mitesco" or the "Company"), today announced that it has executed an agreement with one of its historical investors for up to $30 million in additional financing.

Brian Moses Coaching and Seminars to Provide Exclusive Coaching Content, Sales Training, and Strategic Guidance for Mitesco's AI-Powered Real Estate Platform VERO BEACH, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Mitesco, Inc. (OTCQB: MITI) ("Mitesco" or the "Company"), through its Vero Technology Ventures division, today announced a strategic partnership with Brian Moses, founder of Brian Moses Coaching and Seminars…

Industry Experts Join Initiative to Help Shape Next Generation AI Platform for Real Estate Professionals VERO BEACH, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- Mitesco, Inc. (OTCQB: MITI) (“Mitesco” or the “Company”), through its Vero Technology Ventures division, today announced the official launch of the RoboAgent Test Bed Team, an initiative designed to provide real-world feedback, validation, and industry expertise…